The Advanced Infusion Systems Market is estimated to reach a value of USD 10.3 billion in 2025 and is projected to reach USD 19.1 billion by 2035, registering a CAGR of 6.4%. On the basis of Product Type, Volumetric Infusion Systems are expected to lead the segment, capturing a 38.0% revenue share in 2025. On the basis of Application, Chemotherapy will remain the dominant segment, accounting for a 37.2% market share.